Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Pediatr Nephrol. 2013 Jun 20;28(11):2179–2188. doi: 10.1007/s00467-013-2524-6

Fig. 3.

Fig. 3

The graphs represent the results of contingency tables analyses for Neutrophil Gelatinase-associated Lipocalin (NGAL) alone (A) fibroblast growth factor −2 (FGF-2) alone (B), and both NGAL and FGF-2 combined (C). The predictive abilities of these biomarkers to detect acute kidney injury (AKI) in newborns treated with Hypothermia (HT) or extracorporeal membrane oxygenation (ECMO) were generated using control urine samples collected from healthy newborns, and assuming a 40% prevalence of AKI. The following cut-off values were used at baseline (initiation of therapy: NGAL (1,005 ng/mg UCr) and FGF-2 (56.20 pg/mg UCr).